Want to see SBC full AI Analyst Report?
SBC Stock Chart & Stats
$3.06
$0.13(4.25%)
At close: 4:00 PM EDT
$3.06
$0.13(4.25%)
Day’s Range― - ―
52-Week Range$2.78 - $5.07
Previous Close$3.19
Volume85.85K
Average Volume (3M)65.67K
Market Cap
$370.25M
Enterprise Value$195.63
Total Cash (Recent Filing)$184.62M
Total Debt (Recent Filing)$48.23M
Price to Earnings (P/E)8.2
Beta0.64
Next Earnings
Nov 12, 2026EPS Estimate
0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.47
Shares Outstanding102,846,950
10 Day Avg. Volume48,167
30 Day Avg. Volume65,672
Financial Highlights & Ratios
PEG Ratio2.07
Price to Book (P/B)1.79
Price to Sales (P/S)2.56
P/FCF Ratio12.15
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$8.50Price Target Upside177.78% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.48
Revenue Forecast (FY)$187.35M
Bulls Say, Bears Say
Bulls Say
Network And Revenue GrowthExpanding clinics, patient visits and same-clinic revenue indicate stronger market reach and operating scale. Growth across both new locations and existing clinics can support sustained revenue expansion over the next several quarters.
High Margins And Cash GenerationStrong profitability demonstrates pricing power and cost control, while recent free cash flow broadly matching net income supports earnings quality. These strengths provide internally generated funding for expansion, technology and disciplined investment.
Low Leverage And Growth PlatformsA lightly leveraged balance sheet gives SBC flexibility to invest without substantial financial strain. AI-enabled support, international partnerships and new non-aesthetic services add potential growth platforms beyond the existing clinic base.
Bears Say
Uneven Revenue And Cash-Flow HistoryHistorical swings in revenue and cash conversion make the latest acceleration less predictable. If demand normalizes or expansion costs rise, reported earnings may not translate into consistently strong cash generation.
Aesthetic Concentration And CompetitionHeavy reliance on elective aesthetic treatments exposes SBC to competitive pricing, changing consumer preferences and discretionary demand. Sustained diversification into non-aesthetic services is needed to reduce concentration and stabilize growth.
Nasdaq Governance Compliance RiskThe governance deficiency creates an ongoing compliance and oversight burden until an independent director is added. Failure to cure the issue could weaken investor confidence and potentially affect listing continuity and access to capital.
SBC FAQ
What was SBC Medical Group Holdings’s price range in the past 12 months?
SBC Medical Group Holdings lowest stock price was $2.78 and its highest was $5.07 in the past 12 months.
What is SBC Medical Group Holdings’s market cap?
SBC Medical Group Holdings’s market cap is $370.25M.
When is SBC Medical Group Holdings’s upcoming earnings report date?
SBC Medical Group Holdings’s upcoming earnings report date is Nov 12, 2026 which is in 84 days.
How were SBC Medical Group Holdings’s earnings last quarter?
SBC Medical Group Holdings released its earnings results on Aug 13, 2026. The company reported $0.1 earnings per share for the quarter, missing the consensus estimate of $0.116 by -$0.016.
Is SBC Medical Group Holdings overvalued?
According to Wall Street analysts SBC Medical Group Holdings’s price is currently Undervalued.
Does SBC Medical Group Holdings pay dividends?
SBC Medical Group Holdings does not currently pay dividends.
What is SBC Medical Group Holdings’s EPS estimate?
SBC Medical Group Holdings’s EPS estimate is 0.12.
How many shares outstanding does SBC Medical Group Holdings have?
SBC Medical Group Holdings has 102,846,950 shares outstanding.
What happened to SBC Medical Group Holdings’s price movement after its last earnings report?
SBC Medical Group Holdings reported an EPS of $0.1 in its last earnings report, missing expectations of $0.116. Following the earnings report the stock price went down -0.313%.
Which hedge fund is a major shareholder of SBC Medical Group Holdings?
Currently, no hedge funds are holding shares in SBC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
SBC Medical Group Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$8.50 (177.78% Upside)
$8.50 (177.78% Upside)
Hedge Fund Trend
Decreased
By 200.0K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-44.06%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
36.34%
Trailing 12-Months
Company Description
SBC Medical Group Holdings
SBC Medical Group Holdings Incorporated provides comprehensive operational support to aesthetic and cosmetic clinics across a global footprint, including Japan, Vietnam, the United States, and other international markets. The company delivers a diverse array of administrative and support functions, such as orchestrating marketing and advertising campaigns, offering extensive human resources solutions including talent acquisition and staff training, and streamlining appointment scheduling for franchisee clinics. Furthermore, SBC Medical Group facilitates real estate arrangements for both employee housing and clinic facility rentals, oversees the design and construction of new clinics, and manages the procurement of essential medical equipment and supplies. Additionally, the firm furnishes IT software solutions. The broad spectrum of aesthetic and reconstructive procedures facilitated by SBC Medical Group's supported clinics encompasses both surgical and non-surgical interventions. These include popular treatments such as breast augmentation, liposuction, and various rejuvenation therapies targeting wrinkles, acne, scars, and signs of aging. The offerings also extend to specialized procedures like laser skin toning, double fold eye surgery, rhinoplasty, hair transplants, laser hair removal, cosmetic dental work, tattoo removal, and advanced eye procedures like LASIK, among others. Established in 2000, SBC Medical Group Holdings Incorporated maintains its headquarters in Irvine, California.
SBC Company Deck
SBC Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed multiple strong operational and financial improvements: double-digit revenue growth, a 32% rise in adjusted EBITDA and margin expansion to 41%, network expansion (+34 locations YoY), rising customer metrics, clear multi-brand and AI-driven strategies, and actionable international initiatives. Challenges flagged were manageable in the near term (one-time SG&A items, currency headwind) and longer-term execution risks around AI rollouts, international scaling and diversification away from aesthetic services. On balance, the positives (strong growth, profitability gains, AI and product/brand initiatives, ample capital for disciplined M&A) materially outweigh the noted challenges.View all SBC earnings summariesSBC Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
$8.50
▲(177.78% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Cra International
―
Forrester Research
―
Franklin Covey Company
―
Resources Connection
―
Aeries Technology
―
Ownership Overview
82.36% Insiders
0.49% Mutual Funds
1.93% Other Institutional Investors
14.34% Public Companies and
Individual Investors









